back-button

    Meningococcal Vaccine (Group A, C, Y & W-135)

    Information about Meningococcal Vaccine (Group A, C, Y & W-135)

    Meningococcal vaccine (group a, c, y & w-135) uses

    Meningococcal Vaccine (Group A, C, Y & W-135) is used to prevent meningococcal disease.

    How meningococcal vaccine (group a, c, y & w-135) works

    Meningococcal vaccine (group a, c, y & w-135) is a vaccine.It helps develop immunity by initiating a mild infection. This type of infection does not cause illness, but it does stimulate the body's immune system to produce antibodies to protect against any future infections.

    Common side effects of meningococcal vaccine (group a, c, y & w-135)

    Dizziness, Injection site reaction, Fatigue, Headache

    Available Medicine for Meningococcal Vaccine (Group A, C, Y & W-135)

    Expert advice for Meningococcal Vaccine (Group A, C, Y & W-135)

    • Do not take meningococcal vaccine in acute infections. 
    • Do not take meningococcal vaccine > 25 mg of oral dose.
    • Tell your doctor if you are pregnant, planning to become pregnant or are breastfeeding. 
    • Do not take if patient is allergic to meningococcal vaccine or any of its ingredients. 
    • Do not give if patients exhibiting severe allergic reactions to a preceding dose of vaccine.
    • Patient with sickle cell disease (a group of disorders that affects haemoglobin) or without a working spleen


    Content on this page was last updated on 03 March, 2017, by Dr. Varun Gupta (MD Pharmacology)